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Abstract: Significant amount of research efforts have been dedicated to the 
development of scaffolds for tissue engineering. Although at present most of 
the studies are focused on non-load bearing scaffolds, many scaffolds have 
also been investigated for hard tissue repair. In particular, metallic scaffolds 
are being studied for hard tissue engineering due to their suitable mechanical 
properties. Several biocompatible metallic materials such as stainless steels, 
cobalt alloys, titanium alloys, tantalum, nitinol and magnesium alloys have 
been commonly employed as implants in orthopedic and dental treatments. 
They are often used to replace and regenerate the damaged bones or to 
provide structural support for healing bone defects. Among the common 
metallic biomaterials, magnesium (Mg) and a number of its alloys are 
effective because of their mechanical properties close to those of human 
bone, their natural ionic content that may have important functional roles in 
physiological systems, and their in vivo biodegradation characteristics in body 
fluids. Due to such collective properties, Mg based alloys can be employed as 
biocompatible, bioactive, and biodegradable scaffolds for load-bearing 
applications. Recently, porous Mg and Mg alloys have been specially 
suggested as metallic scaffolds for bone tissue engineering. With further 
optimization of the fabrication techniques, porous Mg is expected to make a 
promising hard substitute scaffold. The present review covers research 
conducted on the fabrication techniques, surface modifications, properties and 
biological characteristics of Mg alloys based scaffolds. Furthermore, the 
potential applications, challenges and future trends of such degradable 
metallic scaffolds are discussed in detail. 
Keywords 
 Magnesium, Porous scaffolds, Biodegradation, Bone, Cartilage 
1. Introduction 
There is a wide variety of biocompatible materials used for 
different orthopedic applications. Among them, metallic biomaterials 
have been specifically utilized to produce an assortment of orthopedic 
implants such as the head of the femoral component of a total hip joint 
replacement (THJR), the tibial tray in a total knee joint replacement 
(TKJR), the stem of the total shoulder joint replacement, and the 
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spinal fusion cage.1,2 Biodegradable metals are a class of 
biodegradable materials that degrade slowly in the body with a 
suitable host reaction elicited by the released degradation products. 
The biodegradable metal should disappear entirely upon fulfilling the 
mission of supporting the tissue regeneration leaving no implant 
residues; hence, no further surgical operation is needed for the 
implant removal.3 
Appropriate biocompatibility, low in vivo corrosion rate and high 
strength are the main parameters for the selection of a metal for the 
mentioned applications.4 The principal issue of metallic implants is 
their loosening due to bone resorption caused by stress shielding, 
weak interfacial bonding between the implant and the bone, and the 
lack of biological anchorage for the growing tissue.2 To address these 
issues, there has been much effort on the development and 
characterization of metal implants with microstructures and properties 
close to those of trabecular bone. Accordingly, these materials are 
called open-cell porous metals, metallic foams, metallic scaffolds, or 
cellular metals with three-dimensional interconnected pores. The pore 
sizes are typically between 200 and 500 μm with total porosity of 50–
75%.5 
The stability of an implant is mainly dependent on both its 
mechanical strength and its fixation ability to the host tissue. In the 
conventional approach, such stability was mostly achieved by means 
of pins, screws and bone cements.6 However, in recent experiments, 
researchers are attempting to improve the fixation by tissue 
engineering techniques.7 For this purpose, the metal is made porous to 
provide a scaffold for the bone tissue to grow into and through the 
pores thus making a suitable bond to the metallic implant.8 Present 
tissue engineering approaches are focused on the development of 
porous scaffolds made of different biomaterials with the aim of 
replacing and restoring the pathologically altered tissues by 
transplantation of the cells.9,10 Such scaffolds for engineering of hard 
tissues need suitable mechanical integrity.11 A porous 3D material 
provides the required pathways for cells to grow, proliferate, and 
differentiate, while the architecture defines the final structure of the 
newly formed bone.12,13,14,15 It is worth mentioning that the 
spontaneous renewal of the bone is restricted to only small defects. 
The treatment of large bone segments caused by tumors, trauma, 
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implant failure, or osteitis is far more challenging to be addressed. An 
ideal bone tissue engineering scaffold must be biocompatible, 
osteoconductive, and biodegradable, with a high mechanical strength 
to fulfil the necessary load-bearing functions.8 Also, it must have 
interconnected porous networks allowing cell migration, vascularization 
and nutrient delivery.16 The challenge to achieve the above mentioned 
properties in existent scaffolds has made bone tissue engineering a 
very popular research field in the last decade in regards to the 
material selections and production techniques.13,17 Although porosity is 
necessary for scaffolds, it considerably reduces the scaffold's strength 
which is vital, in particular, for the repair of large bone defects.18,19 The 
trade-off between the mechanical strength and the porosity is one of 
the main challenges in designing tissue engineered bone scaffolds.6 At 
present, various types of biomaterials have been employed for this 
aim, which are synthetic or naturally-derived. 
2. Advantages and disadvantages of porous 
magnesium-based scaffold compared to other 
scaffolds 
Early 1970s was the starting date for investigations on porous 
biomaterials such as ceramic,20 polymeric,21 and metallic materials,22 
which identified several promising selections for porous implants that 
would allow bone in-growth. Although ceramics have shown 
outstanding corrosion properties, their inherent brittleness makes 
them difficult to be used for load bearing applications.16 Porous 
polymeric scaffolds cannot resist the high mechanical stresses present 
in bone replacement operations.16 This has led researchers to study 
porous metals, based on orthopedic metallic implants, due to their 
greater compressive strength, fracture toughness, and fatigue 
resistance, which are needed for load-bearing applications.6,16 Due to 
the excellent physical and mechanical properties of magnesium 
compared to other permanent (non-degradable) metals, porous 
magnesium and Mg alloys became good candidates to develop 
biodegradable scaffolds for bone treatments.23,24 
Among the metal implants, Mg and a number of its alloys are 
effective because of 1) their mechanical properties, which are close to 
those of human bone, 2) their natural ionic content that has important 
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functional roles in physiological systems, and 3) their in vivo 
biodegradation characteristics in body fluids. Some physical properties 
of Mg alloys, such as high specific strength and elastic modulus, are 
closer to those of natural human bone compared to other traditional 
metal implants.27,28 For example, compared to titanium alloys with the 
elastic modulus of 110–117 GPa, Mg alloys have lower modulus (41–
45 GPa) leading to a decreased stress-shielding effect.29,30 Moreover, 
Mg alloys are 3–16 times stronger than biopolymers and, at the same 
time, they are more ductile compared to bioceramics, which can 
reduce the chance of the device fracturing throughout the implantation 
process. Moreover, compared to polymers, Mg alloys can encourage 
bone growth, which can help the implant to be properly fixed with the 
host bone to potentially allow full healing of bone defects after 
degradation.31,32 Mg is an essential ion in metabolism and its deficiency 
in the body may cause some pathological conditions. Due to such 
collective properties, Mg based alloys can be employed as 
biocompatible, bioactive, and biodegradable scaffolds for load-bearing 
biomedical applications.25,26 Such characteristics encourage employing 
biodegradable Mg and Mg alloys as lightweight metals for load bearing 
orthopedic implants, which would remain in the body and keep 
mechanical stability over a time scale of 3–4 months, while the natural 
bone tissue heals.33,34 
The main challenge for employing Mg and its alloys as an 
implant is its high corrosion rate resulting in the rapid release of 
degradation products in the body.35,36 The low corrosion resistance in 
physiological environments can have an adverse effect on the 
mechanical stability of the implant prior to bone healing.37 Mg's low 
corrosion resistance also leads to the rapid release of hydrogen gas 
and the formation of subcutaneous gas pockets close to the implant. 
These side products would collect around the implant and interrupt the 
tissue healing.38,39 In addition, due to the hydrogen release, a local 
alkalization occurs around the implant, which affects the pH-dependent 
physiological processes in the surrounding area of the implant.17 The 
need for a relatively low corrosion resistance, makes it necessary to 
take relevant measures to control Mg's high corrosion rate.40 This 
review aims to bring together recent studies on Mg and Mg alloys 
based scaffolds with regards to production techniques, surface 
modifications, general properties, potential applications and future 
trends. If Mg based scaffolds with the proper mechanical and corrosion 
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properties can be successfully applied in bone defect treatments, a 
second operation process for the implant removal will be avoided; 
which in turn will aid bone healing, minimize the trauma to the 
patients, and decrease medical costs.41 
3. Design and production methods 
3.1. Titanium wire space holder 
A novel technique for the production of magnesium scaffolds 
using titanium wires as space holder has been recently developed by 
Jiang et al.42 This technique includes three steps: (a) An entangled 
three-dimensional shape is made of titanium wire,43 (b) the prepared 
titanium pattern is utilized as a space holder to generate a 
titanium/magnesium hybrid system by infiltrating the magnesium cast, 
and (c) the titanium space holder is dissolved from the hybrid system 
by hydrofluoric acid (HF) etching at room temperature.42 With this 
approach, it is feasible to formulate porous magnesium scaffolds with 
adjustable pore size and structure.42 Fig. 1 schematically demonstrates 
the abovementioned stages.42 Similar to the shape and dimension of 
titanium wires, the pores in the magnesium scaffold consist of 
channels with pipe-like structures with diameter of approximately 
270 μm. The results of mechanical tests has shown that the produced 
magnesium scaffolds with porosities of 54.2%, 51% and 43.2% had 
elastic modulus of 0.5, 0.6 and 1.0 GPa, and compressive yield 
strengths of 4.3, 4.6 and 6.2 MPa, respectively. Such results are 
comparable to the mechanical properties of natural bone, and thus 
offer potential applications in the treatment of bone defects.42 
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Fig. 1. Schematic design of the titanium wire space holder method for the production 
of porous magnesium scaffold (reproduced with permission of42). 
3.2. Negative salt pattern molding 
Kirkland et al.44 have developed a new multistep technique with 
the aim of production of an ordered open cell porous Mg scaffold with 
controllable porosity and microstructure by a rapid prototyping and 
casting method. For this purpose, as a supersaturated paste, salt 
particles were made with high purity (99.5%). Computer-aided design 
(CAD) models were then engineered as a positive pattern by 3D 
printing of an acrylic polymer infiltrated in a specific salt slurry. Entire 
elimination of the polymer by combustion in air using a burnout cycle 
led to formation of a negative salt pattern which was then infiltrated 
with melted Mg. Following Mg solidification, the salt was dissolved by 
washing in NaOH solution. Similar to the macroscopic shapes of the 
CAD models, a porous Mg scaffold with ordered pores was formed after 
removal of the salt template by solvent washing. A schematic picture 
of the entire process is illustrated in Fig. 244 This research indicates 
that successful manufacture of topologically ordered porous salt 
patterns facilitated the negative replication of the ordered three-
dimensional configuration utilizing pure Mg.44 
 
Fig. 2. Schematic picture of the negative salt pattern molding process: (a) polymeric 
template produced by rapid prototyping, (b) infiltration of produced porous polymer 
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with salt paste, (c) Burning the polymer template and sintering of salt template, (d) 
casting of Mg melt into the produced salt template, and (e) final porous Mg scaffold 
following salt removal (reproduced with permission of44). 
An in vivo study was also carried out on open porous Mg 
scaffolds which had been produced by a negative salt pattern molding 
process on biodegradable AZ91D alloy.45 In this study, a negative 
template was prepared by pouring the moistened NaCl particles into a 
core box. The salt template was then infiltrated by Mg melt in a die 
casting system and the salt particles were then washed out by the 
NaOH solution. This technique resulted in a scaffold with 72–76% 
porosity and a pore size distribution of 10–1000 μm.45 The produced 
Mg scaffold was implanted into the right knee and an autologous bone 
graft from the left patellar groove was implanted into the left knee as 
a control group. Mg scaffolds were significantly corroded after 
3 months, and most of the implanted Mg alloy was degraded. These 
findings confirm that even rapid corroding Mg scaffold has reliable 
biocompatibility with a desirable inflammatory host response in vivo.45 
3.3. Powder metallurgy 
Porous Mg scaffolds can be prepared using a powder metallurgy 
process by mixing the Mg powder and space holder agents. Normally, 
a two-step heat treatment is required in order to burn out the space 
holder agents as well as a sintering process on the pressed powder. 
Seyedraoufi et al.46 produced a Mg-Zn alloy scaffold by blending and 
pressing Mg, 4 wt% Zn and 6 wt% Zn powders with carbamide 
(CO(NH2)2, 15%, 25% and 35% volume contents) with the particle 
size of 200–400 μm. The blended powders were pressed at 100 MPa 
pressure followed by a two-step heat treatment. The first step was 
adjusted to remove the carbamide particles by heating up to 250 °C 
for 4 h. The second step involved the sintering process, by heating up 
to 500, 550, 565 and 580 °C for 2 h. This study found a relationship 
between the mechanical properties and the porosity content. The 
compressive strength and Young's modulus of the Mg-Zn scaffolds 
decreased with increment in porosities at all sintering temperatures. 
Moreover, the temperature of 550 °C was introduced as the optimum 
condition for the sintering process since the highest compressive 
strength and Young's modulus well obtained at this temperature. The 
results of this study confirmed that the produced Mg–Zn scaffolds with 
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21–36% porosity could have superior mechanical properties 
comparable with that of cancellous bone.46 
An example of an open porous magnesium scaffold with 
interconnected pore microstructure produced by powder metallurgy for 
orthopedic applications is shown in Fig. 3, reproduced from the work of 
Yazdimamaghani et al.47 
 
Fig. 3. The cross section of Magnesium scaffold produced by powder metallurgy 
(reproduced with permission of24). 
The main disadvantage of Mg alloys is their low corrosion 
resistance. The presence of porosity adversely affects the corrosion 
resistance by enhancing the surface area exposed to the corrosive 
media.48 In order to control the degradability of Mg scaffolds produced 
by powder metallurgy method, a multilayer polymeric matrix 
composed of polycaprolactone (PCL) and gelatin (Gel) reinforced with 
bioactive glass (BaG) particles has been coated on the surface of Mg 
scaffolds by freeze drying process.49 In this study, Mg powder was 
mixed with carbonate hydrogen ammonium particles as the space 
holder agent with volume content of 35% and particle size of 
approximately 150–300 μm. The mixed powders were then pressed at 
a pressure of 400 MPa. Similar to other powder metallurgy techniques 
for production of Mg scaffolds, the burning out process was carried out 
at 175 °C followed by a 600 °C heat treatment for sintering. When the 
samples were immersed in a simulated body fluid for bioactivity tests, 
the Mg scaffold coated with PCL-BaG presented the best conditions for 
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the deposition of biominerals. Both uncoated and Mg scaffold coated 
with the PCL-BaG entirely corroded after 3 and 7 days. However, 
approximately 87% of Mg scaffold coated with multilayer PCL-
BaG/Gel-BaG coating remained intact after 14 days of immersion in A 
simulated body fluid (SBF).49 
3.4. Hydrogen injection 
In hydrogen injection method, Mg melt is poured in a crucible 
under vacuum, and high pressure hydrogen is introduced into the 
chamber.50 As demonstrated in Fig. 4, the melt is superheated in 
anticipation that the dissolved hydrogen reaches its saturation, and 
then it is solidified into a water-cooled copper mould. Accordingly, the 
melt is solidified upwards uni-directionally and straight pores are 
formed by supersaturated hydrogen during solidification. Changing the 
cooling part position would change the direction of pore growth.50 
Biological characterization on this type of Mg scaffolds by Gu et al.51 
indicated an acceptable corrosion rate and biocompatibility. However, 
there are some concerns about the absence of interconnected pores in 
the scaffolds made by this method of production. 
 
Fig. 4. Schematic representation of the hydrogen injection technique through the Mg 
melt (reprinted with permission of50). 
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3.5. Laser perforation 
Laser perforation technique has been used to produce designed 
porous Mg scaffolds11 since Mg has been known as a machinable 
metal. Porous Mg scaffolds can be developed by laser perforation 
system by means of a programmable multifunctional laser processing 
machine on the casted Mg ingots. The advantage of this method is the 
simplicity to control the structure, size and shape of pores. Normally, 
interconnected and homogeneous pores with round and honeycomb-
like structure can be formed by this technique.11 Geng et al.11 
produced a Mg scaffold with interconnected pores and honeycomb-like 
configuration. The optimum parameters in this study were the pulse 
frequency of 1–10 Hz, width of 0.3 ms, and the effective output of 
100 W. Aligned long cylindrical pores with diameter of about 0.5 mm 
were manufactured within the Mg scaffold. The results confirmed a 
suitable behavior in mechanical properties due to the fewer flaws and 
voids resulting from the control of the fabrication technique.11 Table 1 
summarizes the techniques for producing porous Mg-based scaffolds. 
Table 1. Summary of the Mg scaffold production methods, their advantages 
and disadvantages. 
Production 
methods 
Advantages Disadvantages References 
Titanium 
wire space 
holder 
−Adjustable pore size and 
structure 
−Pipe-like pore structure 
−The use of hydrofluoric 
acid for etching off the 
titanium wires 
[42] 
Negative 
salt pattern 
molding 
−Controllable porosity and 
microstructure 
−Topologically ordered 
porosities 
−Casting equipment [44] and [46] 
Powder 
metallurgy 
−Interconnected pores 
−Easy technique 
−Lack of acceptable 
mechanical integrity and 
corrosion resistance 
[47], [48], 
[49] and [50] 
Hydrogen 
injection 
−Upwards unidirectional 
and straight pores 
−Casting equipment [51] and [52] 
Laser 
perforation 
−Simple to control the 
structure, size and shape 
of pores 
−Interconnected and 
homogeneous pores with 
round and honeycomb-like 
structure 
−Programmable 
multifunctional laser 
processing machine 
[27] 
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4. Biomedical coatings on magnesium scaffolds 
As aforementioned above, the main disadvantage of magnesium 
and magnesium alloy based scaffolds is their high corrosion rate, due 
to the high electrochemical activity of magnesium metal. Corrosion of 
magnesium alloy is rapid and inhomogeneous, as it can be localized 
corrosion. The formation of hydrogen gas cavity due to the faster 
corrosion rate in comparison to the absorption rate is often observed 
in Mg scaffolds. In addition, an alkaline pH shift adjacent to the 
magnesium implant would result in damage to the host tissue. This 
has led to limiting the potential medical application of magnesium as 
implant, stents, and bone screws. Corrosion and degradation can 
drastically reduce the ultimate strength and fatigue life of implants. 
Increasing the surface area by introducing porosity generally increases 
the corrosion rates and accelerates the mechanical failure of the 
implant. To address the long-term safety of porous scaffolds, alloying 
and surface modification of magnesium scaffolds can be useful 
approaches. Altering the microstructure and composition by alloying, 
and surface modification of the scaffolds prior to the implantation, are 
conducted by a variety of materials and methods.16,52,53 Surface 
modifying the scaffolds increases the corrosion resistance. The surface 
modification can be applied by two different processing techniques of 
conversion coatings or deposited coatings.27 Conversion coatings are in 
situ chemical or electrochemical interactions of the magnesium 
scaffolds with the environment which leads to the formation of an 
inorganic ceramic-like coating on the surface. Deposited coatings are 
mostly organic coatings applied by different methods such as spraying, 
painting, spin coating, dip coating, or immersion. Materials used for 
coating should have specific characteristics such as good corrosion 
protection, biocompatibility, osseointegration, bioactivity, and 
controlled biodegradability. Hornberger et al. have comprehensively 
reviewed the different coating methods.27 
Calcium phosphates (CaPs) with similar composition of the bone 
mineral component possess several beneficial properties such as 
excellent bioactivity and osteoconductivity for bone-graft 
applications.54 Promoting new bone formation and developing strong 
interfacial bonding between CaPs biomaterials and the host bone 
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tissue makes this material an appropriate choice for surface 
modification of magnesium scaffolds. 
Hydroxyapatite [Ca10(PO4)6(OH)2, HA], one of different phases 
of the calcium phosphates (CaPs), has been investigated extensively. 
Surface modification by hydroxyapatite coating is an effective method 
for enhancing the corrosion resistance of magnesium scaffolds. 
Although hydroxyapatite has exceptional biocompatibility, bioactivity 
properties, and similar chemical and structural nature as bone, it 
suffers from high brittleness and low strength which limits its 
application in load bearing conditions.55 Therefore, utilizing 
biodegradable magnesium scaffolds with appropriate mechanics, 
coated with hydroxyapatite to enhance corrosion resistance, and to 
enhance bone forming ability can be a promising scaffold for bone 
tissue engineering in load bearing applications.56 Different techniques 
such as sputtering process, electrophoretic deposition, sol–gel process, 
and biomimetic deposits can be used to coat metallic surfaces by 
hydroxyapatite. However, due to the poor heat resistance of 
magnesium, none of these techniques can be used efficiently for 
hydroxyapatite coating of magnesium scaffolds since a high 
temperature treatment will be required to densify the coating.56 
Therefore, one of the promising options to surface modify magnesium 
scaffolds is using electrochemical deposition which includes low 
deposition temperature and is capable of creating uniform coatings 
with controlled thickness and chemical composition.56,57,58 
Hydroxyapatite crystal structure size and morphology can also 
be manipulated by electrolyte concentration and electrochemical 
potential. Recently, researchers found that the morphology of 
hydroxyapatite coating can affect its osteoconductivity and 
biocompatibility. Healing process of bone defects can be accelerated by 
loose hydroxyapatite coating which allows easier infiltration and 
ingrowth of new bone tissue.57,58,59 
One of the main concerns of using magnesium scaffolds is the 
amount of Mg ions and hydrogen gas released by its corrosion. 
Incorporating Zn element in contents of less than 3% can improve the 
corrosion resistance60 and the mechanical properties of magnesium 
scaffolds.56,61 Seyedraoufi et al.59 investigated and optimized different 
parameters of pulse electrodeposition such as peak current density, 
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temperature, and duty cycle to surface modify porous Mg-2 wt% Zn 
scaffolds with nano hydroxyapatite (Ca10(PO4)6(OH)2) coating upon 
post-treatment in alkali solutions. Porous Mg-2Zn (wt%) scaffolds 
were prepared using a powder metallurgy process. Under optimized 
pulse electrodeposition of 1 h, 40 mA cm− 2 peak current density, 
85 °C temperature, and 0.1 duty cycle, followed by post-treatment in 
alkali solutions, uniform nano hydroxyapatite coatings were generated 
on the scaffolds. As shown in Fig. 5, perpendicularly needle-like 
hydroxyapatite crystals with 2–3 μm length with less than 100 nm in 
diameter were created on the surface of the scaffolds. Loose needle-
like hydroxyapatite crystals highly resemble the inorganic apatite 
structure of natural bone.59 
 
Fig. 5. SEM micrographs in the different magnifications of perpendicularly needle-like 
hydroxyapatite (reprinted with permission of59). 
Tricalcium phosphate [Ca3 (PO4)2, TCP] as coating material 
exhibits desirable biocompatibility and bioactivity. However, TCP shows 
poor mechanical strength and crack-growth propagation resistance. In 
contrary to HA which has poor rate of biodegradability, TCP is 
biodegradable. TCP has three polymorphs and among them, β-TCP 
with hexagonal crystal structure and R3CH space group has a slow-
degrading rate.62 In addition, β-TCP shows desired 
osteoimmunomodulatory properties which activates the immune 
response leading to accelerated bone healing process. Favorable 
osteoimmunomodulatory properties adjust the balance between 
osteogenesis and osteoclastogenesis which improve bone 
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regeneration. Chen et al. prepared63 magnesium scaffolds with the 
laser perforation technique and coated them with β-TCP, in an attempt 
to exploit the advantages of β-TCP coating such as osteoconductivity, 
biocompatibility, high chemical stability, slower degradation rate 
compared to magnesium, and osteoimmunomodulatory.63 In this 
study, the importance of β-TCP coating in immune cells and bone cells 
response was emphasized, and the role of immune cells in adjusting 
osteogenesis and osteoclastogenesis balance was investigated. 
Osteoimmunomodulatory property of β-TCP coating demonstrated the 
activated M2 phenotype of macrophage and release of bone 
morphogenetic protein 2 (BMP2). Subsequently, osteogenic 
differentiation of bone marrow stromal cells was observed due to the 
presence of BMP2.63,64 Activated macrophages secrete BMP2 and 
transforming growth factor b (TGF-b). It has been shown that the 
discharging macrophages result in the inhibition of in vivo bone 
formation.65,66,67,68 Thereby, magnesium scaffolds coated with β-TCP 
showed desired osteogenesis over osteoclastogenesis, due to the 
upregulation of osteoinductive molecules secreted by macrophages in 
contact with β-TCP coating.63 
In a similar study, Geng et al. manufactured69 interconnected 
porous magnesium scaffolds utilizing laser perforation technique and 
coated the samples with β-TCP.69 In vitro biodegradation mechanism 
of surface modified scaffolds was evaluated and the osteosarcoma cell 
(UMR106) attachment and proliferation were studied. Fig. 6a shows a 
macrograph of a fabricated porous magnesium scaffold with cylindrical 
aligned pores with 48% porosity before surface modification. Fig. 6b is 
a SEM image of the β-TCP coated scaffolds obtained by chemical 
process of immersion in the mixture of Ca(NO3)2 and Na2HPO4·12H2O 
after alkali-heat pretreatment. 
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Fig. 6. (a) Porous magnesium scaffold prepared by laser perforation technique before 
coating. (b) SEM micrograph of the β-TCP coated scaffolds (reproduced with 
permission of69). 
Comparing the pH change of uncoated magnesium scaffold with 
coated scaffolds incubated in cell culture medium indicates that the pH 
of the β-TCP coated scaffolds was similar to the pH of the control 
group, while the uncoated scaffolds have significantly increased pH 
value. This result confirms the barrier property of β-TCP which 
increases the corrosion resistance of the scaffold and decreases the 
magnesium ion release, and control the pH of the medium.69 In 
addition, β-TCP coating acts as reservoir of calcium and phosphate 
ions around the scaffolds and triggers the bone growth. It has been 
reported that the local supersaturation of the body fluid with calcium 
and phosphate ions enhances the growth of bone.70,71 
Degradation of β-TCP coating on the magnesium scaffold is 
coincident with the regrowth of new calcium and phosphate coating on 
the surface. This effect occurs by two simultaneous mechanisms 
namely increased nucleation and increase of pH values. First, 
degradation of β-TCP increase the magnesium ions release, which in 
turn leads to an elevated calcium concentration that is desired for 
nucleation and growth of the Ca-P compound on the magnesium 
scaffold.69,72,73,74 Concurrently, enhanced ionic activity of apatite at 
higher pH, due to the degradation of magnesium, can increase the 
apatite nucleation and formation of new Ca-P coating.75 
In an attempt to decrease the degradation rate and to increase 
the possible application potential of magnesium scaffolds in the field of 
tissue engineering, further biomedical coating studies have 
investigated various biodegradable materials such as polycaprolactone 
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(PCL),47,76 polycaprolactone-bioactive glass (PCL-BaG),40 and gelatin-
bioactive glass/polycaprolactone-bioactive glass (Gel-BaG/PCL-BaG) 
coatings.49 The results showed drastic enhanced corrosion resistance 
and compressive strength during the immersion in physiological saline 
solution (PSS). The open porous magnesium scaffolds were 
manufactured by a powder metallurgy technique. While the uncoated 
scaffolds degraded completely and lost 100% weight after 72 h, coated 
scaffolds with 3% w/v and 6% w/v PCL showed 36% and 23% weight 
loss, respectively. In addition, 41% and 83% improvement in 
compressive strength, and 24% and 100% enhancement in the elastic 
modulus have been observed, respectively, in 3% w/v and 6% w/v 
PCL coated magnesium scaffolds.47,76 In addition, incorporating 
bioactive glass (BaG) into the coating layer led to improved bioactivity 
and mechanical integrity compared to the uncoated scaffold. 
Formation of an apatite layer on surface modified scaffolds was 
observed after immersion in SBF, which should stimulate biological 
bone ingrowth and prevent micro-cracks and pore channels 
propagation.40 In the next step, utilizing a freeze drying process, 
gelatin (Gel)-bioactive glass (BaG) porous layer was added on top of 
the PCL-BaG layer of the porous magnesium scaffolds. As shown in the 
SEM images of Fig. 7, porous structure of magnesium scaffolds, PCL-
BaG inner layer coating, and Gel-BaG outer layer are distinguishable 
from each other. While the Mg scaffold/PCL-BaG/Gel-BaG coating 
almost remained intact after 14 days in SBF, the non-coated Mg 
scaffold was fully degraded after 3 days and Mg scaffold/PCL-BaG was 
fully degraded after 7 days. In conclusion, the Mg scaffold with PCL-
BaG/Gel-BaG coating showed better bioactivity, higher mechanical 
integrity and corrosion resistance compared to other scaffolds.49 
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Fig. 7. (a,b) low and high SEM magnification of magnesium scaffold. (c,d) top and 
cross-sectional view of magnesium scaffold coated by PCL-BaG layer. (e, f) cross-
sectional view of magnesium scaffold coated with PCL-BaG inner layer and outer layer 
of Gel-BaG. (g) Inside and (h) top view of coated scaffold (reprinted with permission 
of49). 
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5. General properties and evaluations techniques 
5.1. Mechanical properties 
An appropriate mechanical strength and stability is required for 
scaffolds being used in musculoskeletal tissue engineering. Among all 
possible candidates, magnesium alloys attract considerable attention 
due to their desirable mechanical and biodegradation properties. 
During the last decades, researchers have shown increasing interest 
towards magnesium as a potential biodegradable material for bone 
and cartilage tissue engineering.29,40 In terms of mechanical 
properties, magnesium alloys show better characteristics than 
biodegradable polymers such as polyglycolic acid (PGA) or polylactic 
acid (PLA). Furthermore, degradation and biomineralization of 
bioactive materials on the surface on the magnesium scaffolds 
promote osteoblastic activity and ingrowth of the new tissue.35,45 
Cancellous bone is an interconnected porous structure with 
porosity varying within the range of 30% to 95%. It is well known that 
inclusion of porosity into the implants to make the scaffolds, can 
increase the similarity to the bone structure and enhance the ingrowth 
of new tissue, however, it can also compromise the mechanical 
properties. Scaffolds must have adequate strength and stiffness to 
tolerate the physiological loads. The main concern about the use of 
metallic implants, such as magnesium alloys, is the mismatch of 
Young's moduli of the implants and the adjacent bone tissue. This 
inconsistency between mechanical properties results in the inadequate 
loading of the bone that leads to bone stress shielding, can 
subsequently cause bone resorption, implant loosening, formation of 
cracks within the implant, and implant migration.77,78,79,80 Thus, 
implants should have appropriate strength and stiffness matching 
those of bone tissue. By changing the material of the implant, one can 
achieve optimal elastic moduli close to the bone to prevent stress 
shielding. When stress shielding is reduced by changing the material, 
stiffness mismatch can still exist. In order to overcome the stiffness 
mismatch, researchers have made porous implants (scaffolds). Porous 
materials have reduced stiffness mismatches and increased the tissue 
scaffold interaction by bone ingrowth which helps in the fixation of 
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implants in their place.16 However, it is noteworthy to mention that the 
scaffold suffers from drastic decreases in fatigue strength. 
It has been observed that the production method of porous 
magnesium can affect the mechanical behavior and the collapsing 
mechanism of the sample. A short elastic deformation in the initial 
stages of the stress-strain curves of compressive loading has been 
observed in specimens produced by the mechanical perforation 
method81 and by melt casting.42 This behavior indicates the bulk 
deformation of scaffolds under the compression load, however, porous 
magnesium specimens produced by metal foaming method82 and 
powder sintering method48 show local collapse of pores with shortened 
elastic deformation. Following the linear elastic deformation ending at 
the yield strength, normally magnesium samples exhibit a long plateau 
of constant stress.82 
Changing the pore size, pore shape, porosity, and pore 
distribution can affect the mechanical properties.48,83,84 Increasing 
porosity results in the decrease of compression strength, yield 
strength, and Young's modulus.48,83,84 The mechanical properties of 
porous magnesium prepared by the green compacts method using 
carbamide particles as the space holder and under 100 MP uniaxial 
pressure were studied to demonstrate the dependence of mechanical 
properties on pore size and porosity.48 Scaffolds with pore size of 70–
400 μm and porosity of 35–55% were prepared. Compressive strength 
tests showed a decrease in compressive strength and Young's modulus 
with increase in porosity and pore size. Scaffolds with 35% porosity 
and pore size of 250 μm demonstrated 1.8 GPa of Young's modulus 
and 17 MPa peak stress, and scaffolds with pore size of 73 μm and 
porosity of 45% showed 1.3 GPa of Young's modulus and 16 MPa peak 
stress. Considering the mechanical properties of cancellous bone with 
compressive strength and Young's modulus of 0.2–80 MPa and 0.01–
2 GPa,85 mechanical properties of porous magnesium fall in the range 
of cancellous bone which makes this material a suitable option for hard 
tissue regenerative scaffolds. 
5.2. Bio-corrosion behavior 
In contrast to inert materials such as PLA, the increase in bone 
formation and decrease in healing time observed with magnesium 
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implants indicates the potential osteoconductivity and bioactivity of 
magnesium.29,35 The Osteoconductivity of magnesium is induced by the 
precipitation of calcium phosphate on the surface of the implants in an 
in vitro environment due to corrosion.86,87 Biomimetic calcium 
phosphate coatings enhance osteoblast response, impart 
osteoconductive capacity, and reduce the healing time for bone 
defects. Moreover, enhanced cell attachment and ingrowth due to 
calcium phosphate precipitation can lead to reduced corrosion rate.29 
Exposing pure magnesium to air will result in the formation of a 
gray oxide film of magnesium hydroxide on the surface. Recent 
studies31,34,49,88,89,90,91,92,93,94,95 proposed the formation of magnesium 
hydroxide and release of hydrogen bubbles in the electrolytic 
physiological environment upon degradation of magnesium, through 
the oxidation and reduction reactions which are summarize in the 
following reactions: 
Oxidation reaction: Mg→Mg2++2e− 
 
Reduction reaction: 2H2O+2e−→H2(g)+2OH−  
 
Combination reaction: Mg2++2OH−→Mg(OH)2  
Magnesium hydroxide is not highly soluble in water. The 
reaction between magnesium hydroxide and chlorine ions from the 
tissue fluid or any simulated biological fluids leads to production of 
highly water soluble magnesium chloride. The release of hydroxide ion 
from magnesium hydroxide upon reaction with chlorine ions results in 
the local enhancement of the pH value near the host tissue. The 
presence of calcium and phosphate ions in the tissue fluid triggers the 
production of MgxCay(PO4)z(OH)n compounds, such as calcium 
phosphate and/or calcium magnesium phosphate by the interaction 
between Mg2 +, Ca2 +, and PO43 −. These complex bioactive mineral 
products form a deposition layer on the surface of magnesium 
scaffolds and inhibit further corrosion and increase of pH value. It has 
been shown that degradation, and consequently deposition of the 
bioactive passive layers containing calcium, promotes osteoblast 
growth.96,97 
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5.3. Cell/scaffold interactions 
For newly designed materials, cytotoxicity tests including extract 
based assays, direct contact, and indirect contact for investigating the 
cell-scaffold interaction, are conducted by applying International 
Organization for Standardization (ISO) standards 10993-5 and 
10993:12. Although direct contact cell cytotoxicity methods may 
introduce additional information, extract based assays are the most 
common ones.98 These cytotoxicity testing standards are developed for 
non-degradable materials, thus applying them on the degradable 
magnesium scaffolds may not be suitable. Upon immersion of pure 
magnesium inside the extraction medium, visible gas evolution is 
detectable. Strong degradation locally increases the pH value which is 
evident by tuning normally red medium to colorless medium by the 
deprotonization of the phenol red. Rapid degradation of magnesium 
scaffolds in aqueous environment and cell culture media produces 
highly concentrated extracts with magnesium, strong hydrogen 
production, very high osmolalities and pH-values. 
Osmotic shock by this harsh environment can be lethal to the 
cells in vitro and makes the in vitro cell culture evaluation nearly 
impossible for magnesium scaffolds with ISO standards. Active 
transport processes in in vivo environments regulate most of these 
fluctuations. Therefore, most research groups bypass the in vitro tests 
for magnesium scaffolds and directly perform in vivo animal tests, 
which may be problematic from an ethical point of view. In order to 
address these issues one can use an in vitro bioreactor with dynamic 
flow system to simulate the human body situation. However, 
bioreactors are not always available and the need for in vitro 
experiments for magnesium scaffolds can be addressed by 
establishment of reliable test systems. Fischer et al.99 proposed that in 
vitro cytotoxicity tests for magnesium materials must be done under 
physiological conditions corresponds to in cell culture medium 
containing 10% fetal bovine serum. A physiological condition is a CO2 
level of 5%, an O2 level of 20%, temperature of 37 °C, and relative 
humidity of 95%. As proposed, 10 times more extraction medium 
should be used comparing to the recommended volume by the ISO 
standards (EN ISO standards 10993:5 and 10993:12 suggest 
specimen weight to extraction medium to be 0.2 g/mL) to have 
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reliable results for cytotoxicity.99 Dilution of the pure extracts 
decreases the osmolality and high magnesium concentration to avoid 
cell cycle arrest or apoptosis. It is noteworthy to remember that a high 
dilution may eliminate most toxic ionic content from the extracts and 
prevent real cytotoxicity evaluation. On the other hand, cytotoxicity 
studies on biodegradable magnesium scaffolds by the tetrazolium-salt-
based assays such as MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide) and XTT (2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide) 
are prone to experimental errors. Corroded magnesium can interact 
with tetrazolium salts and convert it to formazan, causing misleading 
results in static in vitro assays. Therefore, using these assays should 
be conducted with high level of caution. It is suggested100 to use 
luminescence-based (BrdU) cytotoxicity assays which do not have any 
interference with the corroding magnesium. 
In vitro studies of biodegradable open porous magnesium 
scaffolds confirmed the different response of human osteoblast cells 
(HOB) and fibroblastic cell line (L929) to osmotic and ionic changes. 
HOB showed better survival in higher osmotic solutions but exhibited 
lower proliferation rate comparing to L929 cells in high osmotic 
extracts.101 This behavior may be explained by the cell-type-dependent 
proliferation to cell volume. Cell proliferation can be altered by osmotic 
swelling or shrinkage. Osmotic swollen cells exhibit more cell 
proliferation compared to osmotic shrunk cells. Osmotic shrunk cells 
demonstrate inhibited or delayed cell proliferation in hyperosmotic 
solutions.102 
Zhang et al. Showed extracellular magnesium ions have 
regulatory effects on intracellular free ionized calcium ([Ca2 +]i).103 
Magnesium ions can affect the [Ca2 +]i and K+ channels. It was 
confirmed that [Mg2 +]o regulates the level of [Ca2 +]i and modulate cell 
shapes and metabolism of cultured vascular smooth muscle cells to 
control vascular contractile activities. It is known that [Ca2 +]i 
concentration can critically change the cell cycle, and K+ and Cl− 
channels can influence cell proliferation and cell cycle 
progression.101,102,103,104 By having these facts in mind and considering 
the release of magnesium ions upon corrosion of the scaffold, one can 
correlate the effect of excess magnesium ion inside the extracts and 
the cell cycle arrest or apoptosis. Selective interaction of magnesium 
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ions with each type of cell culture media extracts can change the 
behavior of the magnesium ions, resulting in distinct cytotoxicity 
responses for different cell types. For instance, corrosion of 
magnesium scaffolds in RPMI-1640 + 10% FBS and DMEM + 10% FBS 
showed similar degradation rate under the same cell culture 
conditions. However, significant differences in magnesium ion 
concentrations in two extracts were observed.101 Both original cell 
culture media, namely RPMI-1640 + 10% FBS and DMEM + 10% FBS, 
have similar magnesium ion concentration and protein content. The 
difference in magnesium ion concentration between two media can be 
explained by the higher concentration of l-glutamine amino acids in 
DMEM, which can create complexes with magnesium.101 
5.4. In vivo assessments 
The host tissue interaction with scaffolds, the fate of the 
biodegradable scaffolds, the ingrowth of newly formed tissue, in 
addition to neo-angiogenesis, and inflammatory response, are 
important aspects of tissue engineering which should be considered for 
each scaffold designed for a specific application. 
Three distinct phases have been recognized for the host tissue 
interaction with biodegradable scaffolds. The first phase occurs within 
the first two weeks of implanting the scaffolds and it is mainly 
characterized by the initiation and development of an inflammatory 
host response. This response is basically independent of the 
degradation rate of the scaffolds. This early phase response is 
indicated by the presence of plasma cells, lymphocytes, 
polymorphonuclear leukocytes, and monocytes. The second phase is 
detected by the predominance of monocytes and their differentiation 
to phenotype of macrophages, fibrous tissue encapsulation of the 
implants and neo-angiogenesis. The length of the second phase is 
determined by the rate of biodegradation of the implanted scaffolds. 
Increase in the degradation time would increase the length of the 
second phase. In addition, the presence of the foreign body giant cells 
at the surface of the scaffolds is evident in the second phase by fusion 
or joining the macrophages together. The third phase starts following 
the last steps of the degradation of the scaffold when the scaffold loses 
its integrity and mechanical properties. The formation of a fibrous 
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capsule is accelerated in the third phase. In this step, the scaffolds 
totally lose their mechanical properties and the newly formed tissue 
replaces the scaffold. The scaffolds breakdown into particles, which 
undergo macrophage phagocytosis.105 
As mentioned above, magnesium is naturally found in bone and 
it is the fourth most abundant cation in the human body.106 Witte et al. 
studied the behavior of host tissue response to open porous 
magnesium alloy AZ91D scaffolds during 3 and 6 months of 
implantation. Porous scaffold were prepared by casting in a negative 
salt pattern molding. 
Although 2 weeks after the implantation gaseous bubbles were 
observed nearby the rabbit knees, all these bubbles disappeared within 
1 week. No adverse events such as body weight loss, abnormal 
behavior, inflammation, damage to neighboring tissues, enhanced cell 
infiltrate into scaffold site, osteolysis, and sterile sinuses were 
detected. Chloracetatesterase histochemistry was used for detecting 
neutrophile granulocytes, which represent the initial stage in 
inflammatory response, and no significant inflammatory processes 
were observed for magnesium scaffolds. Healing happens in 3 
consequent stages of formation of fibrous capsule, angiogenesis, and 
bone formation. Fibrous capsule formation, which was accompanied 
with newly formed blood vessels, and later bone formation and 
ingrowth into the degraded scaffolds were detected in Mg and Mg alloy 
scaffolds. New bone formation at the interface of magnesium scaffolds 
due to osteoconductive properties advocates the fibrosis elimination 
and complete replacement with new bone tissue in later stages of the 
healing process.45 Biomineralized bone volume detected by von Kossa 
stain in the vicinity of the degrading magnesium scaffolds revealed 
significantly higher density of bone growth comparing to the control 
side. This is suggested to be due to the increased osteoblastic and 
osteoclastic activities in the proximity of the degrading magnesium 
scaffold which resulted in formation of more mature bone structure. 
Compared to the control site, reduced trabecular separation and higher 
trabecular number were observed, indicating formation of a more 
mature bone with a superior mechanical properties and 
osseointegration process.107,108 
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Liu et al.89 studied the in vivo biodegradability and osteogenicity 
of porous magnesium scaffolds by implantation inside the femoral 
condyle of male New Zealand white rabbits.89 Porous magnesium 
scaffolds were prepared by machining the extruded pure magnesium 
bars and surface modified by microarc oxidation technology. 
Histological examination on the heart, kidney, spleen, and liver 
exhibited normal morphology, confirming good biocompatibility of the 
both porous magnesium scaffold and control scaffolds. However, 
significant differences in degradation and new bone formation between 
magnesium scaffolds and control scaffolds were detected. This has 
been confirmed by micro-CT scans of 3 months post-operation 
scaffolds (Fig. 8).89 
 
Fig. 8. Micro-CT image of (a) magnesium scaffold and (b) hydroxyapatite scaffold as 
control group. The new bone tissue in-growth is shown in green colour (reprinted with 
permission of89). 
It is noteworthy to mention that in the X-ray images of the 
magnesium scaffold, bubbles appeared around the implanted scaffolds 
after 2 weeks due to the degradation of magnesium and formation of 
hydrogen gas. Although surface modifications was used to reduce the 
degradation rate and to decrease hydrogen generation, formation of 
mild swelling in rabbits knees starting from 2 weeks and persisting for 
2 months, indicated inadequate thickness of magnesium oxide and 
surface treatment.89 However, these findings show that even fast 
degrading magnesium scaffolds demonstrate good biocompatibility, 
suitable inflammatory response, and bone regeneration, which makes 
open porous magnesium scaffolds good candidates for bone and 
cartilage tissue engineering.45 
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6. Applications 
6.1. Bone 
One of the most important advantages of the biodegradable 
magnesium scaffolds over conventional permanent metal scaffolds is 
total in vivo corrosion of the scaffolds and elimination of the additional 
surgery step of scaffolds removal. This will help to reduce the health 
risks, costs, and improve the patient compliance.47,99,101 
In long term applications such as bone implants, the magnesium 
scaffold must have slow rate of degradation to allow cell proliferation 
and ingrowth. Increased surface area in porous scaffolds leads to an 
increase in the corrosion rate. To control the degradation rate in such 
application, magnesium alloys are prepared. Incorporating yttrium to 
magnesium can increase the corrosion resistance. It is well known that 
yttrium element stimulates the grain refinement, increases 
cytocompatibility, and reduces the corrosion rate of 
magnesium.109,110,111 Bobe et al. added 4 wt% yttrium to magnesium 
and made open porous scaffolds by liquid phase sintering technique 
using magnesium short fibers.101 As shown in the Fig. 9a, fibers with a 
diameter of 100–250 μm and a length of 4–8 mm under argon 
atmosphere were manufactured utilizing crucible melt extraction 
technique. Deposition of fibers on a tantalum substrate with an MgO 
sieve, with further liquid phase sintering, and subsequently additional 
heat treatment produced a bulk porous material which was finally cut 
into cylindrical porous scaffolds as shown in Fig. 9d. Light microscopy 
determined 58 to 63% porosity for the scaffolds. Mechanical analysis 
of the prepared scaffolds showed Young's modulus within the range of 
human cancellous bone, and compression strength exceeding that of 
human cancellous bone. 
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Fig. 9. (a) Melt extraction procedure to manufacture short fibers. (b) Deposition of Mg 
alloy fibers onto a moving substrate with an MgO barrier, then sintered and cut by 
laser jet method. (c) SEM cross sections of fibers demonstrates the sinter bonds 
(bar = 20 μm). (d) Cylindrical scaffolds before in vitro or in vivo tests 
(bar = 1000 μm). (e) SEM image of scaffold surface (bar = 200 μm) (reprinted with 
permission of101). 
In vivo implantation of open porous scaffolds in femoral condyle 
of female rabbits demonstrated no severe clinical signs of gas cavities 
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or inflammation. In general, rabbits showed normal foreign body giant 
reaction towards the implanted scaffolds with no pathological changes 
in the histology of the internal organs including lung, liver, pancreas, 
kidney, heart, spleen, and intestine or any blood abnormalities. In 
addition, no signs of necrotic tissue or fibrous encapsulation were 
found at 6 weeks or at 12 weeks after implantation. Moreover, 
osteoblasts and osteoclast cells remodeling bone around and inside the 
scaffold were observed at 6 and 12 weeks respectively. However no 
signs of gas cavities were detected clinically. Postoperative 
microtomographs (Fig. 10) showed some entrapped gas cavities after 
6 weeks around the implanted scaffolds. These gas cavities demolished 
within 12 weeks. Slow in vivo scaffold degradation and almost intact 
scaffolds after 6 weeks were detected by microtomography. Fig.10b 
shows evidence of new bone formation adjacent to the scaffolds. Slow 
in vivo scaffold degradation proceeds to 12 weeks and at this time only 
7% volume of the scaffold remained. 
 
Fig. 10. (a) Tomograms of scaffolds before the implantation show open inter-
connected porous structure with no residual materials. (b) At 6 weeks, newly formed 
bone marked by white dots, and gas cavities showed by white star. (c) 12 weeks no 
gas cavity is detectable. (White arrow heads indicates metallic implant and black arrow 
heads show corroded parts) (scale bar = 1 mm) (reprinted with permission of101). 
6.2. Cartilage 
Hyaline articular cartilage tissue lacks the sufficient regenerative 
potential due to absence of blood vessels in their structure. Therefore, 
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all required nutrition agents and growth factors are being transferred 
by diffusion from the bone marrow and remote blood vessels. Cartilage 
nutrition is supported by the subchondral bone plate, thus any 
damages such as osteochondral defects can prevent regenerating 
cartilage. In such cases, using a biodegradable scaffold as the 
subchondral bone plate can enhance the cartilage healing 
process.112,113,114 Ideal scaffolds in subchondral bone plate tissue 
engineering should provide adequate mechanical stability, appropriate 
pore size, sufficient porosity, and optimized programmed degradation. 
Gradual degradation provides more space for ingrowth of new tissue 
and blood vessels.47,115,116,117 
The degradation profile of scaffolds for cartilage repair should 
warrant two months of suitable mechanical integrity, and afterwards 
rapid degradation to allow the infusion of nutrition and reparative cells 
towards the healing site. Magnesium scaffolds were studied as the 
subchondral bone plate to induce cartilage repair.118 Magnesium alloy 
(AZ91) with 75% porosity showed rapid degradation at twelve weeks 
postoperatively. Although no signs of negative influence were detected 
at the adjacent cartilage tissue, no adequate subchondral bone plate 
regeneration was observed. Furthermore, histological studies showed 
no significant cartilage regeneration above the degraded magnesium 
scaffold. Similar results have also been observed using autografted 
cancellous bone as the replacement of the subchondral bone plate.118 
This finding is surprising since the autograft is believed to be the best 
and first option for regenerative tissue engineering due to its 
immunocompatibility. Application of autografts is mainly limited by 
inadequate availability, and donor bone site morbidity.119,120 
Comparison studies using autografted cancellous bone and magnesium 
scaffold for osteochondral defects confirm the necessity for the 
unconstrained access to nutrition and reparative cells from the bone 
marrow.118,120 Therefore, the designed scaffolds should satisfy the need 
for local blood circulation and bone marrow accessibility. On the other 
hand, in the untreated osteocartilage defect with the highest 
accessibility to bone marrow cavity, no reproduction of subchondral 
bone in the central part was observed.118 Magnesium scaffolds with 
optimal porosity should provide appropriate mechanical support,47,48 
osteoinductive properties, excellent biocompatibility,121 
biodegradability and bioresorbability.122 Thus, such scaffolds can be 
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designed to be suitable candidates for subchondral bone plate 
replacement. 
7. Conclusion and future work 
Porous scaffolds for biomedical applications such as orthopedic 
reconstructive surgery continue to attract research attention, which is 
confirmed by the ever-increasing number of publications on this 
subject. Metallic biomaterials have great potential as the basic 
materials to develop such scaffolds, especially for load-bearing 
applications due to their high mechanical properties compared to 
biodegradable polymeric materials. Recently introduced Magnesium 
and its alloys appear to have the potential to be suitable biodegradable 
metallic materials with similar mechanical properties as those of bone. 
Mg and Mg alloys have shown encouraging results when used as tissue 
engineering scaffolds. This review summarized the common methods 
for fabricating porous Mg-based scaffolds. It also explored some of the 
surface modification methods, biological performance, and applications 
of Mg-based scaffolds. While a considerable number of studies 
encourage the use of magnesium alloys in bioactive and biodegradable 
implants for load bearing orthopedic applications, a great deal of 
research is still essential to fully assess the in vivo long-term capability 
of such scaffolds. The possibility of magnesium being employed as a 
reliable metallic scaffold calls for persistent research and study on in 
vitro osteoblast cell attachment, proliferation, differentiation to an 
osteoblast phenotype, formation of bone matrix, studies of bone 
apposition, tissue regeneration, and finally in vivo bone healing 
including introduction of angiogenesis. In fact, the application of 
biodegradable metallic scaffolds bone tissue engineering is just at the 
beginning. Controlling the degradation rate of magnesium in body 
fluids can be the first step to advance the field, which may be achieved 
through the use of alloying elements, casting and forming techniques, 
composite fabrication and/or surface coatings. The possible 
cytotoxicity of the modified systems will also require further 
verification. A great deal of research is still needed to develop 
superior, straightforward, and more cost-effective modification 
methods to facilitate the full use of the biodegradability, mechanical 
strength, and improved bio-functional properties of Mg alloys. In 
addition, rapid prototype methods could be considered to produce 
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porous scaffolds with properties purposely tailored for the cell 
regeneration and the tissue in-growth. Future research directions 
include understanding the effect of porosity on the corrosion and 
mechanical properties, the cell regeneration and tissue healing in the 
porous structure, developing procedures for manufacturing suitable 
porous Mg scaffolds, and finally control over the degradation rate of 
the scaffolds. Furthermore, integrating Mg scaffolds with biopolymers, 
bioactive ceramics and drugs represents a new promising path to 
investigate. 
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